The Fetal Medicine Foundation 19th World Congress in Fetal Medicine, Crete, Greece
Abstracts
 
  • Aneuploidies
  • Defects
    • CNS
    • Face
    • Heart
    • Lungs
    • Gastrointestinal
    • Kidneys
    • Skeleton
    • Other
  • Fetal therapy
  • Impaired placentation
  • GDM / Obesity
  • Preterm birth
  • Congenital infection
  • Maternal conditions
  • Labour / Delivery
  • Multiple pregnancies
  • Placenta
  • Other

Congenital infection

  1. An Artificial Neural Network model for severe COVID-19 prediction in pregnant women View pdf
  2. Anxiety and depressive symptoms in pregnant women during COVID-19 pandemic in large Czech sample View pdf
  3. Cortical maturation assessed by MRI in unaffected/mildly affected fetuses with cytomegalovirus infection View pdf
  4. Covid 19 and pregnancy View pdf
  5. COVID-19 Vaccine Acceptance in Pregnancy View pdf
  6. Differential endothelial and angiogenic profile of preeclampsia versus COVID-19 in pregnancy View pdf
  7. Early Adverse Events and Immune Response Following COVID-19 Booster Vaccination in Pregnancy View pdf
  8. Effectiveness of valaciclovir for prevention of fetal infection following early gestational primary maternal cytomegalovirus infection View pdf
  9. Endothelial dysfunction and inflammation cell signaling triggered by preeclampsia versus COVID-19 in pregnancy View pdf
  10. Endotheliopathy biomarkers and angiogenic factors in distinguishing preeclampsia from COVID-19 in pregnancy View pdf
  11. Impact of the COVID-19 Outbreak on Routine Obstetrical Management View pdf
  12. Increased Ɣ -Glutamyl Transpeptidase and Ɣ-Glutamyl Transpeptidase/Platelet Ratio: Biological Markers of Severe Brain Damage in Cytomegalovirus Infected and Uninfected Fetuses View pdf
  13. Influence of intraamniotic infection/inflammation on fetal corpus callosum View pdf
  14. Maternal and perinatal outcomes of SARS-CoV-2 infection in early pregnancy: a population-based study from first trimester to delivery View pdf
  15. Mental well-being among pregnant and postpartum women during the COVID-19 pandemic: a large international survey View pdf
  16. Obstetric and Neonatal Outcomes following COVID-19 Vaccination in Pregnancy View pdf
  17. Ocular Congenital Toxoplasmosis View pdf
  18. One year of first trimester universal screening for Cytomegalovirus at two tertiary referral centers in Barcelona (Catalunya, Spain) View pdf
  19. PRECORSE study: Seroprevalence of SARS-CoV-2 in the first trimester of pregnancy during the pandemic outbreak and subsequent pregnancy complications. A cohort study View pdf
  20. Prevalence of Risk factors associated with adverse mental health outcomes in Colombian pregnant women during the Covid 19 pandemic View pdf
  21. SARS-CoV-2 infection in pregnant women: experience of a Tunisian Maternity View pdf
  22. Serological and clinical response to SARS-CoV-2 infection and vaccination during twin pregnancies View pdf
  23. Severe COVID-19 infection and associated laboratory abnormalities and perinatal outcomes View pdf
  24. Shared risk factors for COVID-19 and preeclampsia in the first trimester: An observational study View pdf
  25. The association between history of Severe Acute Respiratory Coronavirus 2 infection and altered glucose metabolism in pregnancy View pdf
  26. The impact of antenatal care modifications during the COVID-19 pandemic on gestational diabetes mellitus outcomes View pdf
  27. The relationship between the prevalence of Group B streptococcus colonization and ritual water immersion among Jewish families View pdf
  28. Trends in management and outcomes of pregnant women living with HIV in 2008-2019: a retrospective cohort study View pdf
  29. What does the “halo” sign mean in fetal cytomegalovirus infection? View pdf
38394278402642023797406842063916407040713816405339934037404040143923402042714116416740133798418840623806388138274273
© 2022 The Fetal Medicine Foundation